Human Apoptotic Cells, Generated by Extracorporeal Photopheresis, Modulate Allogeneic Immune Response
Author(s) -
Caroline Pilon,
Thomas Stehlé,
Asma BeldiFerchiou,
Marie Matig,
Allan Thiolat,
Aude Burlion,
Cynthia Grondin,
Brigitte Birebent,
France Pirenne,
Hélène Rouard,
Philippe Lang,
Gilles Marodon,
Philippe Grimbert,
José L. Cohen
Publication year - 2019
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/fimmu.2019.02908
Subject(s) - extracorporeal photopheresis , immune system , transplantation , immunology , photopheresis , apoptosis , medicine , in vivo , cancer research , biology , graft versus host disease , surgery , microbiology and biotechnology , lymphoma , biochemistry
The induction of specific and sustainable tolerance is a challenging issue in organ transplantation. The discovery of the immunosuppressive properties of apoptotic cells in animal models has paved the way for their use in human transplantation. In this work, we aimed to define a stable, reproducible, and clinically compatible production procedure of human apoptotic cells (Apo-cells). Using a clinically approved extracorporeal photopheresis technique, we have produced and characterized phenotypically and functionally human apoptotic cells. These Apo-cells have immunosuppressive properties proved in vitro and in vivo in NOD/SCID/γC mice by their capacity to modulate an allogeneic response following both a direct and an indirect antigen presentation. These results brought the rationale for the use of Apo-cells in tolerance induction protocol for organ transplantation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom